Introduction
Diabetes mellitus is associated with various types of metabolic vascular dysfunction mediated by sustained elevation of plasma glucose levels (Calles-Escandon and Cipolla, 2001; Ceriello, 2003) . In major diabetic complications, including angioneurosis, retinopathy and nephropathy, it is generally accepted that dysfunction of micro-resistant arteries is responsible for perivascular tissue damage (Ostergaard et al., 2005; Yu and Lyons, 2005) . Endothelial cells (EC), which regulate vascular tonus via nitric oxide synthesis (Cohen, 2005) , serve as a barrier at the interface of vascular tissue (Lum and Malik, 1994) . The increase in EC layer permeability in local resistant artery is thought to be an early manifestation of EC barrier dysfunction and its induced diabetic complications. For example, enhancement of EC layer permeability can lead to edema and proliferative diabetic retinopathy (Qaum et al., 2001) . Based on this perspective, evidence corresponding to the relationship between alteration of oxidative stress and/or NO synthesis and complications of diabetic hyperglycemia has accumulated (Prabhakar, 2004; Santilli et al., 2004; Niedowicz and Daleke, 2005) . In contrast, studies have indicated that glucose-induced enhancement of EC layer permeability is dependent on protein kinase C (PKC) activity in the absence of mediation of the calcium-NO synthesis pathway (Dang et al., 2005) . According This article has not been copyedited and formatted. The final version may differ from this version.
JPET Fast Forward. Published on May 12, 2006 as DOI: 10.1124 at ASPET Journals on jpet.aspetjournals.org Downloaded from JPET #105015, Page-7 to these findings, critical conclusions with respect to alteration of EC function in diabetic hyperglycemia have not been established.
We previously reported that the inflammatory factor thrombin induces enhancement of EC layer permeability (Nobe et al., 2005) , which is mediated via a two-step process: 1) Interaction of EC-to-EC adhesion molecules, namely, vascular endothelial cadherin (VE-CaD), was disrupted during the initial stage of thrombin stimulation; cell-to-cell connections were decreased. 2) EC indicated force development (non-muscle contraction) characterized by morphological changes; cell-to-cell distances increased, resulting in the formation of paracellular holes. We concluded that these sequential steps play a central role in alteration of EC layer permeability. To detect EC force development, a re-constituted EC fiber technique was introduced. This EC fiber was re-constituted in a collagen matrix, which made possible detection of absolute force development in cultured EC. Utility of this EC fiber force measurement system revealed that the thrombin-induced responses involved two distinct pathways, which operated as intracellular signaling pathways. Reduced VE-CaD signals were associated with a calciumdependent pathway, whereas EC contraction was associated with a calcium-independent pathway. However, alterations of these pathways under high-glucose (HG) conditions, as in diabetes, are poorly understood.
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JPET Fast Forward. Published on May 12, 2006 as DOI: 10.1124 at ASPET Journals on jpet.aspetjournals.org Downloaded from JPET #105015, We previously demonstrated that EC-replaced mouse aorta (Nobe et al., 2003) and portal vein (Nobe et al., 2004b) contractions were induced by treatment with the thomboxane A 2 (TXA 2 ) analogue, U46619.
These contractions were significantly enhanced under HG conditions; furthermore, intracellular diacylglycerol (DG) level and PKC activity were elevated during this enhancement. Similar changes were also described in other types of tissues (Ramana et al., 2005; Rolo and Palmeira, 2006) . We suggested over-acceleration of phosphatidylinositol (PI) turnover as a possible mechanism of enhanced vascular contraction. Incorporated glucose is converted to DG via a de novo synthesis pathway under HG conditions; as a result, excess accumulation of DG was believed to be a key step in vascular dysfunction as this situation might lead to activation of PKC. Additionally, similar accumulation of DG was observed. Alteration of this vascular smooth muscle contraction might be associated with diabetic complications. We hypothesized that EC function was also influenced under HG conditions in a manner identical to that of smooth muscle dysfunction. However, alteration of EC function due to U46619 has not been examined. We believe that a thorough understanding of alteration of U46619-induced EC function and its intracellular mechanisms are of utmost importance in order to facilitate the establishment of a new target for care in diabetic complications.
The objective of this investigation was to identify the contribution of extracellular glucose This article has not been copyedited and formatted. The final version may differ from this version.
JPET Fast Forward. Published on May 12, 2006 as DOI: 10.1124 at ASPET Journals on April 30, 2017 jpet.aspetjournals.org Downloaded from JPET #105015, Page-9 accumulation to U46619-induced EC layer permeability. Subsequently, the relationships of both VE-CaD response and EC contraction to alteration of EC layer permeability were evaluated as the major mechanisms of diabetic vascular dysfunction.
Materials and Methods
Reagents. Bovine aortic endothelial cells were provided by Dr. S. Shimizu (Dept. of Pathophysiol., Showa Univ., Tokyo). Calf serum and Dulbecco's modified Eagle's medium (DMEM) containing 11.1 mM (2 g/L) glucose were obtained from Life Technologies (Grand Island, NY, USA). Rat tail collagen type-I was procured from Upstate Biotechnology (Lake Placid, NY, USA). Fura-2/AM, BAPTA/AM, Alexa 488-phalloidine and SYTO-17 were acquired from Molecular Probes (Eugene, OR, USA).
Thromboxane A 2 analogue (U46619), phospholipase C inhibitor (U73122), and SQ29548 were purchased from Sigma Chemical Co. (St. Louis, MO, USA). Rho kinase inhibitor (Y-27632) and Rottlerin were obtained from Wako Pure Chemical Corporation (Osaka, Japan) and Funakoshi Corporation (Tokyo, Japan), respectively. Vascular endothelial cadherin (VE-CaD) antibody was acquired from Alexis This article has not been copyedited and formatted. The final version may differ from this version. Nobe, et al.(Nobe et al., 2005) . Rat tail collagen (Type-I) solution was neutralized with 0.1 N NaOH in an ice bath. Dispersed cells were suspended in a solution containing 1 X 10 7 cells/mL and 0.5 mg/mL collagen in DMEM. A cell suspension (2 mL) was poured into a specially designed mold (0.8 cm X 5 cm X 0.5 cm deep), which was cut into a layer of silicone rubber in a 60-mm dish, and placed in a CO 2 incubator at 37 o C. EC fiber preparations were incubated for three days. In a manner identical to that of the monolayer EC culture, DMEM was exchanged daily. Measurement of EC Layer Permeability. EC layer permeability was measured as described previously (Imai-Sasaki et al., 1995; Nobe et al., 2005 ] i was measured as described previously (Nobe et al., 2005) .
Measurement of Isometric
VE-cadherin Immunostaining. VE-cadherin immunostaining was conducted as previously In order to assess the influence of HG treatment on cell-to-cell connections in the EC layer, alteration of vascular endothelial cadherin (VE-CaD) was measured (Fig. 2) . In the non-stimulated resting state under normal glucose conditions, the presence of VE-CaD connections was evident ( Fig. 2A) . VE-CaD signals were detected for more than 90% of cell junction components. U46619 (10 µM) challenge induced disruption of VE-CaD connections in time-dependent fashion. After 60 min of stimulation, VECaD signals remained for only 5-10% of cell junctions. Rather, cell-to-cell distances increased and paracellular holes formed after 60 min of stimulation. Pre-incubation of EC under HG conditions did not influence the resting VE-CaD signal (Fig. 2B) ; however, addition of 10 µM U46619 induced rapid (3 min) disruption of the VE-CaD connections. More than 90% of the signals disappeared during the initial 3-min period. Moreover, formation of paracellular holes was advanced.
Results

U46619-induced Enhancement of EC Responses
To elucidate the mechanisms, effects of a PKC inhibitor (rottlerin) and a DG kinase inhibitor (stemphone) on U46619-induced VE-CaD depression were also examined. In normal-PSS, U46619- Isometric force development of EC accompanied by morphological changes, i.e., paracellular hole formation, was determined using three-dimensionally re-constituted EC fibers (Fig. 3) . EC fibers were pre-incubated in normal-and HG-DMEM for 48 hr in a manner consistent with that of the aforementioned experiments; subsequently, 5-mm sections were mounted on a specially designed isometric force measurement system. The length was increased to match the original fiber length in the mold. Following stress relaxation, the force attained a baseline level of 20.30 ± 0.27 µN (n = 5).
Treatment with 10 µM U46619 induced sustained force development in normal glucose-PSS (Fig. 3 ).
This response was time-dependent. Pre-treatment of EC fibers with HG-DMEM slightly increased the non-stimulated resting level (29.30 ± 1.86 µN; n=5). Although U46619 treatment led to an increase in sustained force development, the increase was rapid and the response was large. Maximal force responses, including baseline, to U46619 under normal and HG conditions after the 60-min period were 45.00 ± 1.80 and 63.80 ± 3.14 µN, respectively (n=5). Significant enhancement of U46619-induced force development under HG conditions was observed from 3 min of stimulation. In order to confirm alteration of EC fiber contractility in HG-PSS, increased force value in the initial 5 min of U46619 stimulation was calculated as the "initial rate" (Fig. 3B-inset ). This initial rate was significantly elevated from 2.49 ± This article has not been copyedited and formatted. The final version may differ from this version. were pre-treated with the intracellular calcium inhibitor, BAPTA/AM, for 30 min prior to U46619 treatment ( Fig. 4A-inset) . The transient increases in [Ca 2+ ] i under normal and HG conditions were suppressed (34.83 ± 1.70 and 39.67 ± 2.54 nM, respectively) without affecting resting levels. Differences between normal-and HG-PSS could not be detected in intracellular calcium measurements.
The effects of some kinds of inhibitors in terms of enhancement of EC layer permeability under HG conditions were examined (Fig. 4B ). U46619-induced enhancement of EC layer permeability under normal and HG conditions was confirmed (195.95 ± 6.67 and 279.40 ± 3.59 µg/cm 2 , respectively; n=5).
In a manner identical to that of Fig. 4A , the EC layer was pre-treated with 1 µM BAPTA/AM for 30 min.
Significant inhibition of permeability in normal-and HG-PSS was detected (81.70 ± 4.05 and 150.40 ± 10.75 µg/cm 2 , respectively; n=5); however, differences between the two glucose conditions remained.
Other key factors of EC function, particularly the association of PKC and DG kinase with EC layer permeability, were also evaluated employing rottlerin and stemphone as specific inhibitors. These substances display a tendency to inhibit calcium-independent isoforms of PKC or DG kinase. Treatment were observed following treatment with stemphone (53.78 ± 1.71 and 54.10 ± 3.10 µg/cm 2 , respectively; n=5). These inhibitors also suppressed differences between normal and HG conditions. Inhibitory effects were also evident upon introduction of calphostin C or R59022 (data not shown). These conventional inhibitors cannot distinguish between calcium-dependent and -independent isoforms.
The roles of rho and the rho kinase pathway in U46619-induced EC fiber contraction were examined in order to discern alteration of sustained function following completion of intracellular calcium events under HG conditions (Fig. 5) . The rho kinase inhibitor, Y27632 (1 µM), markedly reduced U46619-induced force development under normal and HG conditions (Fig. 5A , 5B). The maximal force developments in the presence of Y27632 were 22.50 ± 0.83 and 23.80 ± 1.13 µN (n=5), respectively.
Differences between normal and HG conditions were suppressed. Although the initial rate of the response was also diminished, significant differences between normal-and HG-PSS remained (Fig. 5C ).
As a downstream of the Rho-Rho kinase pathway, actin stress fiber (ASF) formation was measured ( formation was also reduced following Y27632 treatment in normal-and HG-PSS.
Discussion
The current investigation examined EC barrier dysfunction under HG conditions. Experiments involved enhancement of both VE-CaD disruption and EC contraction. Several studies have shown that TXA 2 plays an important role in diabetic vascular complications (Davi et al., 1990; Kobayashi et al., 2005 ). This importance is based mainly on the low concentration (0.1-30 nM) of the TXA 2 analogue, U46619, necessary to induce significant contraction in diabetic models (Pfister et al., 2004) . We also documented 10 nM U46619-induced sub-maximal contractions in mouse aorta (Nobe et al., 2003) , portal vein (Nobe et al., 2004a) and porcine coronary artery (Nobe and Paul, 2001 receptor-mediated time-and dose-dependent increases in EC layer permeability were detected within this range (Fig. 1) . Moreover, previous reports demonstrated that similar levels of TXA 2 induced enhancement in EC layer permeability in other types of EC (Chang and Ohara, 1993) , which was consistent with the response obtained in this study. During U46619 treatment, cell-to-cell connector, e.g., VE-CaD, signals were reduced (Fig. 2 ) and significant increases in EC fiber contraction (Fig. 3) were observed. These responses were similar to those of thrombin stimulation (Nobe et al., 2005) , which suggested that thrombin and U46619 induced both disruption of VE-CaD signals and EC contraction, which were mediated by common mechanisms in EC layer permeability. Contraction of EC in U46619-induced enhancement of EC layer permeability was identified in this investigation; however, it appears that this phenomenon preferentially accompanies hyperglycemia rather than solely elevating TXA 2 in diabetes. accordance with our previous experiments involving vascular smooth muscle tissue (Nobe et al., 2004a; Nobe et al., 2004b) . We previously confirmed that HG medium treatment induced neither hyperosmolar nor non-selective actions (data not shown). Moreover, HG-induced responses in this investigation were sub-maximum; higher concentration (22.2 mM <) and long-term treatment (48 hr <) were not dependent on increases in EC response (data not shown). Reports appearing in the literature indicate that viability and cellular functions of rataortic EC were maintained under similar HG conditions (Lee et al., 2004 ).
These results suggested that similar HG treatment of EC led to enhancement of non-stimulated basal EC layer permeability; however, meaningful differences were not detected in the current study. Although several possibilities exist regarding these differences (EC species, culture conditions, etc.), a critical cause remains unknown.
Under HG conditions, U466619-induced EC layer permeability was enhanced (Fig. 1) . EC layer permeability was not derived from enhancement of TXA 2 receptor sensitivity (Fig. 1B-inset) . Similar enhancement was not evident under high-sucrose conditions (11.1 mM sucrose added to normal medium for 48 hr); alteration of EC layer permeability was caused by an increase in extracellular glucose concentration. In our preliminary measurements, enhanced EC layer permeability in HG medium was recovered upon restoration of EC to normal glucose medium, although it was slow and incomplete (data This article has not been copyedited and formatted. The final version may differ from this version. In order to elucidate the mechanism(s) governing EC layer alteration under HG conditions, both VE-CaD signal (Fig. 2) and EC contraction (Fig. 3) were examined; moreover, alterations of both parameters were observed. These findings indicated that these alterations are directly attributable to enhancement of EC layer permeability. However, questions regarding intracellular mechanisms associated with extracellular glucose level abound. A major contractile factor, [Ca 2+ ] i was measured during U46619 stimulation in normal and HG mediums. A transient increase in intracellular calcium response was detected; however, the response was not dependent on extracellular glucose concentration (Fig. 4A) . Inhibition of the transient increase in [Ca 2+ ] i by BAPTA/AM did not suppress the EC layer response. Importantly, significant differences between the two glucose conditions remained in the presence of BAPTA/AM (Fig. 4B) . We hypothesized that extracellular glucose influenced a point downstream of the calcium signaling pathway or the calcium-independent signaling pathway.
Downstream of the calcium signaling pathway, the association of PKC and DG kinase activities with EC function was assessed consequent to over-activation of PKC and DG kinase, which leads to dysfunction This article has not been copyedited and formatted. The final version may differ from this version. and DG kinase inhibitor suppressed reduction of U46619-induced EC layer permeability as well as differences between normal and HG mediums (Fig. 4B) . As a result of these treatments, differences of VE-CaD signals under normal and HG conditions were also diminished (Fig. 2) . These findings suggested that elevated extracellular glucose accelerated PI-turnover mediated by PKC-DG kinase activities; additionally, it induced enhancement of the disruption rate of VE-CaD signals (Fig. 6A, 6B ).
Interestingly, inhibitors of PKC (rottlerin) and DG kinase (stemphone) possess selectivity for calcium-independent isoforms (De Witt et al., 2001; Nobe et al., 2004a) . We hypothesized that the elevated response of EC under HG conditions is mediated by the calcium-independent PKC-DG kinase pathway. We previously reported that incorporated glucose under HG conditions is converted to a nonnatural species of DG via a de novo synthesis pathway in rat and mouse vascular smooth muscle cells (Nobe et al., 2004a) . As a preliminary measurement, we also measured a phospholipase C. Depended on the DG formation from extracellular glucose, total PKC activity was also increased (data not shown). Other investigators documented similar findings (Marignani et al., 1996; Deacon et al., 2002) . In EC, data suggested that the elevation in extracellular glucose induces accumulation of the non-natural DG species as well as PKC activation; furthermore, this phenomenon might contribute to the rapid disruption of VE-CaD signals. Several groups reported that b-catenin, a regulatory factor of VE-CaD, is phosphorylated by PKC (Berk et al., 1995; Sandoval et al., 2001) , which leads to an un-coupling of VE-CaD connections (Fig. 6A, B) ; in contrast, other researchers noted that activation of PKC is not involved in VE-CaD regulation (Vouret-Craviari et al., 1998) . Regulatory mechanisms of this point remain incomplete; however, the current results are consistent with those of the former investigations.
In our preliminary trials employing the non-selective PKC inhibitor, calphostin C (1 µM pretreatment for 10 min), and the calcium-dependent PKC inhibitor, Gö6976 (1 µM pre-treatment for 10 min), U46619-induced VE-CaD disruption was detected exclusively following calphostin C application (data not shown). These results supported the possibility that increased disruption of VE-CaD under HG conditions is mediated by a calcium-independent PKC-DG kinase pathway. (Fig. 3B-inset) ; additionally, this enhancement remained despite the presence of a rho kinase inhibitor (Fig. 5C ). These findings were also suggestive of the importance of regulation of VE-CaD disruption by the calcium-independent PKC-DG kinase pathway.
We previously noted that disruption of VE-CaD connections was insufficient for the thrombininduced increase in EC layer permeability (Nobe et al., 2005) . It was suggested that EC contraction also contributed to the increase in EC layer permeability consequent to paracellular holes. Rho and the rho kinase-mediated calcium-independent signaling pathway were involved; furthermore, rho and the rho kinase pathway may contribute to U46619-indcued EC contraction. In U46619-induced EC contractions, initial rate and maximal force developments were significantly enhanced under HG conditions (Fig. 3 ).
These responses were followed by ASF formation (Fig. 5D ). Pre-treatment with a rho kinase inhibitor markedly reduced maximal contraction and ASF formation without suppressing differences in initial rates between normal and HG conditions (Fig. 5) . These findings revealed that rho/rho kinase-mediated ASF re-arrangements are correlated with U46619-induced EC contraction ( paracellular hole formation by Y27632 also provided evidence regarding the importance of this pathway (Fig. 5D) . Additionally, inhibition of EC-layer permeability by Y27632 was also confirmed under same condition of Fig. 5D (data not shown) . Alteration of EC layer permeability under HG conditions might entail an increase in VE-CaD signal disruption in the initial period as well as a secondary step consisting of over-contraction of EC.
The current investigation demonstrated that dysfunction of the EC layer under HG conditions, as in diabetes, is associated with both the rapid, extracellular glucose-dependent disruption of VE-CaD connections during the initial period as well as with the ensuing rho kinase-ASF-mediated EC overcontraction. In the initial phase, accumulation of the glucose-derived non-natural DG species stimulated calcium-independent PKC and DG kinase isoforms, which might lead to an increase in VE-CaD disruption. In the contraction phase, the rho-rho kinase pathway was also activated by elevation of extracellular glucose level, which results in paracellular hole formation via over-contraction of EC. This sequential process contributes to enhancement of EC layer permeability under HG conditions. Reactions were terminated with 4% paraformaldehyde. Samples were permeabilized with 0.1% triton-X100. Cells were exposed to anti-VE-CaD antibody and SYTO-17 for nuclear staining as described in "Methods". Samples were visualized with Alexa-fluora-488 anti-rabbit IgG. Fluorescent images of Alexa fluora-488 (green) and SYTO-17 (red) were collected employing confocal laser microscopy. Scale bar = 30 µm. Following confirmation of stable resting levels, 10 µM U46619 was added. Each line indicates the average of typical cellular responses in the same microscopic field. Peak calcium responses were summarized (A-inset). BAPTA/AM (1 µM) was introduced 30 min prior to U46619 addition. In a manner similar to that of the calcium measurement, EC-layer permeability was measured as described in 
